---
schema_version: "secwatch.filing_event.v1"
accession: "0001649094-26-000026"
form_type: "8-K"
ticker: "PCVX"
cik: "0001649094"
company_name: "Vaxcyte, Inc."
filed_at: "2026-06-23T20:09:09+00:00"
generated_at: "2026-06-23T20:10:38.108555+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Vaxcyte director Jacks Lee retires; Moncef Slaoui appointed to board

## Summary
- Jacks Lee retired from the Board effective June 17, 2026; no disagreement with the company.
- Lee entered a consulting agreement for global strategic supply and manufacturing operations.
- Moncef Slaoui appointed as Class II director effective June 17, 2026; term expires at 2028 annual meeting.
- Slaoui deemed independent under Nasdaq rules; will receive standard non-employee director compensation with annual equity grant valued at $430,000.

## SEC filing metadata
- accession: 0001649094-26-000026
- form_type: 8-K
- ticker: PCVX
- cik: 0001649094
- company_name: Vaxcyte, Inc.
- filed_at: 2026-06-23T20:09:09+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000026/0001649094-26-000026-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000026/pcvx-20260617.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001649094-26-000026
- JSON: https://secwatch.observer/filing/0001649094-26-000026.json
- Plain text: https://secwatch.observer/filing/0001649094-26-000026.txt

## Key facts
- Executive change
  Moncef Slaoui was appointed as Class II Director at Vaxcyte, Inc..
  - Action: appointed
  - Role: Class II Director
  source text: On June 17, 2026, upon recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Moncef Slaoui to the Board as a Class II director, which appointment became effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000026/0001649094-26-000026-index.htm
- Executive change
  Jacks Lee retired as Director at Vaxcyte, Inc..
  - Action: retired
  - Role: Director
  source text: On June 17, 2026, Jacks Lee notified the Board of Directors (the “Board”) of Vaxcyte, Inc. (“the “Company”) of his retirement from the Board, effective as of June 17, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1649094/000164909426000026/0001649094-26-000026-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.